The Role of Exosomes in Pancreatic Cancer Microenvironment
- 1.1k Downloads
Exosomes are nanovesicles shed by cells as a means of communication with other cells. Exosomes contain mRNAs, microRNAs (miRs) and functional proteins. In the present paper, we develop a mathematical model of tumor–immune interaction by means of exosomes shed by pancreatic cancer cells and dendritic cells. Cancer cells’ exosomes contain miRs that promote their proliferation and that inhibit immune response by dendritic cells, and by CD4+ and CD8+ T cells. Dendritic cells release exosomes with proteins that induce apoptosis of cancer cells and that block regulatory T cells. Simulations of the model show how the size of the pancreatic cancer can be determined by measurement of specific miRs (miR-21 and miR-203 in the case of pancreatic cancer), suggesting these miRs as biomarkers for cancer.
KeywordsTumor growth Exosomes Math modeling Partial differential equation Free boundary problem
The authors have been supported by the Mathematical Biosciences Institute and the National Science Foundation under Grant DMS 0931642.
- Ding G, Zhou L, Qian Y, Fu M, Chen J, Chen J, Xiang J, Wu Z, Jiang G, Cao L (2015) Pancreatic cancer-derived exosomes transfer miRNAs to dendritic cells and inhibit RFXAP expression via miR-212-3p. Oncotarget. doi: 10.18632/oncotarget.4924
- Fadeev RS, Chekanov AV, Dolgikh NV, Akatov VS (2012) Increase in resistance of A431 cancer cells to TRAIL-induced apoptosis in confluent cultures. Biofizika 57(4):649–654Google Scholar
- Hosgood HD, Zhang L, Tang X, Vermeulen R, Qiu C, Shen M, Smith MT, Ge Y, Ji Z, Xiong J, He J, Reiss B, Liu S, Xie Y, Guo W, Galvan N, Li L, Hao Z, Rothman N, Huang H, Lan Q (2011) Decreased numbers of CD4(+) naive and effector memory T cells, and CD8(+) naive T cells, are associated with trichloroethylene exposure. Front Oncol 1:53Google Scholar
- Lin J, Li J, Huang B, Liu J, Chen X, Chen XM, Xu YM, Huang LF, Wang XZ (2015) Exosomes: novel biomarkers for clinical diagnosis. Sci World J 2015:657086Google Scholar
- MacGill M (2013) Pancreatic cancer: chemo drug Gemzar improves survival rates. Medical News TodayGoogle Scholar
- McDonald D (2010) Understanding miRNA turnover: a study of miRNA half-life. Broad Insitute, CambridgeGoogle Scholar
- Oliver JC, Bland LA, Oettinger CW, Arduino MJ, McAllister SK, Aguero SM, Favero MS (1993) Cytokine kinetics in an in vitro whole blood model following an endotoxin challenge. Lymphokine Cytokine Res 12(2):115–120Google Scholar
- Pilch J, Namysłowski G, Scierski W, Urbaniec P, Sowińska-Krzyzanowska I (2006) Interleukin 2 concentration changes in the laryngeal cancer patients during the surgical treatment. Otolaryngol Pol 60(3):331–336Google Scholar
- Sonkoly E, Loven J, Xu N, Meisgen F, Wei T, Brodin P, Jaks V, Kasper M, Shimokawa T, Harada M, Heilborn J, Hedblad MA, Hippe A, Grander D, Homey B, Zaphiropoulos PG, Arsenian-Henriksson M, Stahle M, Pivarcsi A (2012) MicroRNA-203 functions as a tumor suppressor in basal cell carcinoma. Oncogenesis 1:e3CrossRefGoogle Scholar
- Troy AJ, Summers KL, Davidson PJ, Atkinson CH, Hart DN (1998) Minimal recruitment and activation of dendritic cells within renal cell carcinoma. Clin Cancer Res 4(3):585–593Google Scholar